UroGen Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
CEOElizabeth Barrett
CEOElizabeth Barrett
Employees235
Employees235
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2004
Founded2004
Employees235
Employees235
URGN Key Statistics
Market cap1.33B
Market cap1.33B
Price-Earnings ratio-8.22
Price-Earnings ratio-8.22
Dividend yield—
Dividend yield—
Average volume1.08M
Average volume1.08M
High today$28.87
High today$28.87
Low today$27.39
Low today$27.39
Open price$28.13
Open price$28.13
Volume803.35K
Volume803.35K
52 Week high$30.00
52 Week high$30.00
52 Week low$3.42
52 Week low$3.42
Stock Snapshot
As of today, UroGen Pharma(URGN) shares are valued at $28.46. The company's market cap stands at 1.33B, with a P/E ratio of -8.22.
On 2025-12-02, UroGen Pharma(URGN) stock traded between a low of $27.39 and a high of $28.87. Shares are currently priced at $28.46, which is +3.9% above the low and -1.4% below the high.
The UroGen Pharma(URGN)'s current trading volume is 803.35K, compared to an average daily volume of 1.08M.
During the past year, UroGen Pharma(URGN) stock moved between $3.42 at its lowest and $30.00 at its peak.
During the past year, UroGen Pharma(URGN) stock moved between $3.42 at its lowest and $30.00 at its peak.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.